Zhen Su - 31 Aug 2023 Form 3 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/Nancy Smith as Attorney-in-Fact for Zhen Su
Issuer symbol
KPTI
Transactions as of
31 Aug 2023
Net transactions value
$0
Form type
3
Filing time
01 Sep 2023, 08:17:21 UTC
Next filing
22 Mar 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.